The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance

Journal of Affective Disorders

Volumn 151, Issue 2, 2013, Pages 582-589

  Maremmani, Angelo Giovanni Icro ^a,b   Rovai, Luca ^a   Bacciardi, Silvia ^a   Rugani, Fabio ^a   Pacini, Matteo ^a,c   Paolo Pani, Pier ^d   Osso, Liliana Dell' ^e   Akiskal, Hagop ^f   Maremmani, Icro ^a,b,c  

^a UNIVERSITY OF PISA   (Italy)

^b AU CNS   (Italy)

^c G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^d Territorial Department of Nephrology and Dialysis   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dual diagnosis; High threshold methadone maintenance programme; Long term outcome; Methadone maintenance

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DIAMORPHINE; METHADONE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; COHORT ANALYSIS; COMORBIDITY; DSM-IV; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; TREATMENT OUTCOME; URINALYSIS;

DUAL DIAGNOSIS; HIGH-THRESHOLD METHADONE MAINTENANCE PROGRAMME; LONG-TERM OUTCOME; METHADONE MAINTENANCE;

ADULT; BIPOLAR DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885480820     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.06.054     Document Type: Article

References (66)

1. A.P.A. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV 1994 American Psychiatric Association Washington
2. L. Amato, S. Minozzi, M. Davoli, and S. Vecchi Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification Cochrane Database System Review 9 2011 CD005031
3. E. Änggård Disposition of methadone in methadone maintenance Clinical Pharmacology & Therapeutics 17 1974 258 266
4. A.L. Bahorik, C.E. Newhill, and S.M. Eack Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization Addiction 108 2013 1259 1269
5. M. Baigent Managing patients with dual diagnosis in psychiatric practice Current Opinion in Psychiatry 25 2012 201 205
6. T. Blaney, and R.J. Craig Methadone maintenance. Does dose determine differences in outcome? Journal of Substance Abuse Treatment 16 1999 221 228
7. K.T. Brady, and S.C. Sonne The relationship between substance abuse and bipolar disorder Journal of Clinical Psychiatry 56 1995 19 24
8. T.M. Brady, S. Salvucci, L.S. Sverdlov, A. Male, H. Kyeyune, E. Sikali, S. DeSale, and P. Yu Methadone dosage and retention: An examination of the 60 mg/day threshold Journal of Addictive Diseases 24 2005 23 47
9. S.J. Cacciola, A.I. Alterman, M.J. Rutherford, J.R. McKay, and F.D. Mulvaney The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients Drug and Alcohol Dependence 61 2001 271 280
10. A. Camacho, and H.S. Akiskal Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers Journal of Affective Disorders 85 2005 217 230
11. C.H. Chen, S.C. Wang, H.H. Tsou, I.K. Ho, J.N. Tian, C.J. Yu, C.F. Hsiao, S.Y. Chou, Y.F. Lin, K.C. Fang, C.L. Huang, L.W. Su, Y.C. Fang, M.L. Liu, K.M. Lin, Y.T. Hsu, S.C. Liu, A. Chen, and Y.L. Liu Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients Pharmacogenomics 12 2011 1397 1406
12. D. D'Ippoliti, M. Davoli, C.A. Perucci, F. Pasqualini, and A.M. Bargagli Retention in treatment of heroin users in Italy: The role of treatment type and of methadone maintenance dosage Drug and Alcohol Dependence 52 1998 167 171
13. S. Darke, K. Mills, M. Teesson, J. Ross, A. Williamson, and A. Havard Patterns of major depression and drug-related problems amongst heroin users across 36 months Psychiatry Research 166 2009 7 14
14. V.P. Dole, and H. Joseph Long term outcome of patients treated with methadone maintenance Annals of the New York Academy of Sciences 311 1978 181 189
15. F. Faggiano, F. Vigna-Taglianti, E. Versino, and P. Lemma Methadone maintenance at different dosages for opioid dependence Cochrane Database System Review 3 2003 CD00 2208
16. A. Fareed, J. Casarella, M. Roberts, M. Sleboda, R. Amar, S. Vayalapalli, and K. Drexler High dose versus moderate dose methadone maintenance: is there a better outcome? Journal of Addictive Diseases 28 2009 399 405
17. M. Farrell, S. Howes, C. Taylor, G. Lewis, R. Jenkins, P. Bebbington, M. Jarvis, M. Brugha, B. Gill, and H. Meltzer Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric morbidity survey Addictive Behaviors 23 1998 909 918
18. J. Fernandez Miranda, M. Gonzalez Garcia-Portilla, P. Saiz Martinez, E. Gutierrez Cienfuegos, and J. Bobes Garcia Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment Actas Luso-Espanolas de Neurologia, Psiquiatria y Ciencias Afines 29 2001 228 232
19. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version 1997 American Psychiatric Publishing, Inc Arlington, VA, USA
20. D.J. Foster, A.A. Somogyi, and F. Bochner Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4 British Jornal of Clinical Pharmacology 47 1999 403 412
21. P.D. Friedmann, S.C. Lemon, B.J. Anderson, and M.D. Stein Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS) Drug and Alcohol Dependence 69 2003 243 251
22. M. Gelkopf, T. Weizman, Y. Melamed, M. Adelson, and A. Bleich Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an israeli methadone maintenance clinic Israel Journal of Psychiatry and Related Sciences 43 2006 126 136
23. G. Gerra, F. Borella, A. Zaimovic, G. Moi, M. Bussandri, C. Bubici, and S. Bertacca Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome Drug and Alcohol Dependence 75 2004 37 45
24. A. Gonzalez-Pinto, S. Alberich, S. Barbeito, M. Alonso, E. Vieta, A. Martinez-Aran, M. Saenz, and P. Lopez Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study Journal of Affective Disorders 124 2010 250 255
25. B. Goodwin, M.R. Redimbo, and S.A. Kliewer Regulation of CYP3A gene transcription by the Pregnane X receptor Annual Review of Pharmacology and Toxicology 42 2002 1 23
26. W. Guy ECDEU Assessment Manual for Psychopharmacology. Clinical Global Impressions 1976 U.S. Department of Health, Education, and Welfare Rockville, MD
27. J.C. Hoblyn, S.L. Balt, S.A. Woodard, and J.O. Brooks 3rd Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder Psychiatric Services 60 2009 50 55
28. E.D. Kharasch, and K. Stubbert Role of cytochrome P4502B6 in methadone metabolism and clearance Journal of Clinical Pharmacology 53 2013 305 313
29. S. Kritz, M. Chu, C. John-Hull, C. Madray, B. Louie, and L.S. Brown Jr. Opioid dependence as a chronic disease: The interrelationships between length of stay, methadone dose, and age on treatment outcome at an urban opioid treatment program Journal of Addictive Diseases 28 2009 53 56
30. B. Lovrecic, M. Lovrecic, L. Rovai, F. Rugani, S. Bacciardi, L. Dell'Osso, A.G.I. Maremmani, and I. Maremmani Ethnicity and drug addiction. A comparison between Italian and Slovenian heroin addicts Heroin Addiction and Related Clinical Problems 14 2012 5 18
31. M. Maj, R. Pirozzi, L. Magliano, and L. Bartoli Agitated depression in bipolar I disorder: prevalence, phenomenology, and a outcome American Journal of Psychiatry 160 2003 2134 2140
32. A.G.I. Maremmani, S. Bacciardi, L. Rovai, F. Rugani, L. Dell'Osso, and I. Maremmani Natural history of addiction in psychotic heroin addicted patients at their first Agonist Opioid Treatment Addictive Disorders and Their Treatment 12 2013 31 39
33. A.G.I. Maremmani, L. Rovai, and I. Maremmani Heroin addicts' psychopathological subtypes. Correlations with the natural history of illness Heroin Addiction and Related Clinical Problems 14 2012 11 22
34. A.G.I. Maremmani, L. Rovai, F. Rugani, M. Pacini, F. Lamanna, S. Bacciardi, G. Perugi, J. Deltito, L. Dell'Osso, and I. Maremmani Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients Frontiers in Psychiatry 3 (61) 2012 1 11
35. I. Maremmani, A.G.I. Maremmani, F. Rugani, L. Rovai, M. Pacini, S. Bacciardi, J. Deltito, L. Dell'Osso, and H.S. Akiskal Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry Annals of General Psychiatry 11 (23) 2012
36. I. Maremmani, M.R. Capone, M. Aglietti, and P. Castrogiovanni Heroin dependence and bipolar disorders New Trends in Experimental and Clinical Psychiatry X 1994 179 182
37. I. Maremmani, and P. Castrogiovanni DAH-Q: Drug Addiction Questionnaire 1989 University Press Pisa
38. I. Maremmani, M. Pacini, F. Lamanna, P.P. Pani, G. Perugi, J. Deltito, I.M. Salloum, and H.S. Akiskal Mood stabilizers in the treatment of substance use disorders CNS Spectrums 15 2010 95 109
39. I. Maremmani, M. Pacini, G. Perugi, J. Deltito, and H. Akiskal Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: Clinical observations and a proposed pathophysiologic model Journal of Affective Disorders 106 2008 55 61
40. I. Maremmani, M. Pacini, D. Popovic, A. Romano, A.G. Maremmani, G. Perugi, J. Deltito, K. Akiskal, and H. Akiskal Affective temperaments in heroin addiction Journal of Affective Disorders 117 2009 186 192
41. I. Maremmani, P.P. Pani, S. Canoniero, M. Pacini, G. Perugi, Z. Rihmer, and H.S. Akiskal Is the bipolar spectrum the psychopathological substrate of suicidality in heroin addicts? Psychopathology 40 2007 269 277
42. I. Maremmani, P.P. Pani, M. Pacini, and G. Perugi Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients Journal of Substance Abuse Treatment 33 2007 91 98
43. I. Maremmani, G. Perugi, M. Pacini, and H.S. Akiskal Toward a unitary perspective on the bipolar spectrum and substance abuse: Opiate addiction as a paradigm Journal of Affective Disorders 93 2006 1 12
44. I. Maremmani, O. Zolesi, M. Aglietti, G. Marini, A. Tagliamonte, M. Shinderman, and S. Maxwell Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity Journal of Addictive Diseases 19 2000 29 41
45. M. Mazza, L. Mandelli, M. Di Nicola, D. Harnic, V. Catalano, D. Tedeschi, G. Martinotti, R. Colombo, P. Bria, A. Serretti, and L. Janiri Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up Journal of Affective Disorders 115 2009 27 35
46. Y. Oda, and E.D. Kharasch Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation Journal of Pharmacology and Experimental Therapeutics 298 2001 1021 1032
47. P.P. Pani, I. Maremmani, R. Pirastu, A. Tagliamonte, and G.L. Gessa Buprenorphine: a controlled clinical trial in the treatment of opioid dependence Drug and Alcohol Dependence 60 2000 39 50
48. P.P. Pani, E. Trogu, P. Contu, A. Agus, and G.L. Gessa Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program Drug and Alcohol Dependence 48 1997 119 126
49. E. Peles, S. Schreiber, and M. Adelson 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel Drug and Alcohol Dependence 107 2010 141 148
50. H.A. Pollack, and T. D'Aunno Dosage patterns in methadone treatment: results from a national survey, 1988-2005 Health Services Research 43 2008 2143 2163
51. S. Reif, M.J. Larson, D.M. Cheng, D. Allensworth-Davies, J. Samet, and R. Saitz Chronic disease and recent addiction treatment utilization among alcohol and drug dependent adults Substance Abuse Treatment, Prevention, and Policy 6 2011 28
52. B.J. Rounsaville, J. Cacciola, M.M. Weissman, and H.D. Kleber Diagnostic concordance in a follow-up study of opiate addicts Journal of Psychiatric Research 16 1981 191 201
53. B.J. Rounsaville, M.M. Weissman, H. Kleber, and C. Wilber Heterogeneity of psychiatric diagnosis in treated opiate addicts Archives of General Psychiatry 39 1982 161 166
54. M. Sajatovic, R.V. Ignacio, J.A. West, K.A. Cassidy, R. Safavi, A.M. Kilbourne, and F.C. Blow Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic Comprehensive Psychiatry 50 2009 100 107
55. G. Salamina, R. Diecidue, F. Vigna-Taglianti, P. Jarre, P. Schifano, A.M. Bargagli, M. Davoli, L. Amato, C.A. Perucci, and F. Faggiano Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study Substance Use & Misuse 45 2010 2076 2092
56. I. Schafer, F.J. Eiroa-Orosa, U. Verthein, C. Dilg, C. Haasen, and J. Reimer Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment Psychopathology 43 2010 88 95
57. F. Schifano, A.M. Bargagli, V. Belleudi, L. Amato, M. Davoli, R. Diecidue, E. Versino, F. Vigna-Taglianti, F. Faggiano, and C.A. Perucci Methadone treatment in clinical practice in Italy: need for improvement European Addiction Research 12 2006 121 127
58. F.R. Schneier, T.E. Foose, D.S. Hasin, R.G. Heimberg, S.M. Liu, B.F. Grant, and C. Blanco Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions Psychological Medicine 40 2010 977 988
59. M. Shinderman, S. Maxwell, M. Brawand-Amey, K.P. Golay, P. Baumann, and C.B. Eap Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses Drug and Alcohol Dependence 69 2003 205 211
60. I. Siassi, B.P. Angle, and D.C. Alston Comparison of the effect of high and low doses of methadone on treatment outcome International Journal of the Addictions 12 1977 993 1005
61. E.C. Strain, M.L. Stitzer, I.A. Liebson, and G.E. Bigelow Methadone dose and treatment outcome Drug and Alcohol Dependence 33 1993 105 117
62. I. van Rossum, M. Boomsma, D. Tenback, C. Reed, and J. van Os Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis Journal of Nervous and Mental Diseases 197 2009 35 40
63. K. Verebely, J. Volavka, S. Mule, and R. Resnick Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment Clinical Pharmacology & Therapeutics 18 1975 180 190
64. J.S. Wang, and C.L. DeVane Involvement of CYP3A4, CYP2C8 and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro Drug Metabolism and Disposition 31 2003 742 747
65. G.R. Wilkinson Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans Journal of Pharmacokinetics and Biopharmaceutics 24 1996 475 490
66. L.T. Wu, W. Ling, B. Burchett, D.G. Blazer, J. Shostak, and G.E. Woody Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network Substance Abuse and Rehabilitation 2010 2010 13 22